top
Search terms
Results 1 - 10 of 10 - ordered by :
Escardio

DOI 10.1093/ehjcvp/pvy038 Comment In this issue of European Heart Journal – Cardiovascular Phamacotherapy (Vol 5, Issue 1, January 2019), Dr Januzzi and co-workers from the USA report data from ...

Date : 31/01/2019
Escardio

In a recent paper published in “Circulation” a surprising message is published about an unfavourable evolution in the management and funding of cardiovascular diseases (McClellan M. et ...

Date : 06/05/2019
Escardio

Stress-related pathophysiological changes, such as lowered arrhythmic threshold and increased sympathetic activation with related increases in blood pressure and heart rate, as well as ...

Date : 24/04/2018
Escardio

The primary endpoint-prevention of reduction in EF of ≥10 percentage points from baseline to 6 months was not reached (about 14% in both the carvedilol and placebo group), but the carvedilol group ...

Date : 30/11/2018
Escardio

The cases may include information on investigational uses of compounds/drugs that have not been approved by regulatory authorities. Martin Möckel, MD, PhD, FESC, FAHA Full Professor and AHF ...

Date : 28/06/2017
Escardio

Belgium For the 10th consecutive year, the Belgian Working Group on Heart Failure (BWGHF), Belgian Working Group on Cardiovascular Nursing and the Belgian Cardiologic League join their forces to ...

Date : 14/05/2019
Escardio

Here we organize: meeting of doctors and patients after cardiac surgery and transplantation not only of the heart, but also of other organs press-conference lighting the problem of HF culinary master ...

Date : 22/03/2019
Escardio

OSLER-1 and OSLER-2 Clinical Trials Evolocumab, a monoclonal antibody that inhibits pro-protein convertase subtilisin-kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) ...

Date : 20/10/2015
Escardio

The Working Group organised: HFA awareness session as a part of congress of Armenian Cardiologists Association with involvement of President of ACA, principal cardiologist of Ministry of Health and ...

Date : 13/02/2018
Escardio

National CVD Prevention Coordinators (NCPCs) for Italy: Pompilio Faggiano, Brescia, and Salvatore Novo, Palermo, Italy Report repared by Prof. Salvatore Novo with the collaboration of Antonino ...

Date : 19/08/2015